(Reuters) - Merck & Co Inc said it would buy Cubist Pharmaceuticals Inc for $8.4 billion plus assumption of debt, giving the major drugmaker an entry into the market for drugs that combat so-called superbugs.
via Health News Headlines - Yahoo News http://ift.tt/1ue3gDA
No comments:
Post a Comment